JP Patent

JP5010279B2 — ジメトキシドセタキセル・アセトン溶媒和物およびその製造方法

Assigned to アベンティス・ファーマ・ソシエテ・アノニム · Expires 2012-08-29 · 14y expired

What this patent protects

Patent listed against Jevtana Kit.

Drugs covered by this patent

Jevtana Kit (cabazitaxel) · Accord Hlthcare

Patent Metadata

Patent number: JP5010279B2
Jurisdiction: JP
Classification: —
Expires: 2012-08-29
Drug substance claim: No
Drug product claim: No
Assignee: アベンティス・ファーマ・ソシエテ・アノニム
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.